Introduction
Psychotic disorders such as schizophrenia affect approximately 5 in every 1,000 Australian adults each year, yet they account for a disproportionate share of specialised mental health service activity and long-term disability (Australian Institute of Health and Welfare [AIHW], 2024). The burden extends well beyond symptoms. Australians living with severe mental illness die up to two decades earlier than the general population, largely from preventable cardiometabolic disease rather than from the illness itself (National Mental Health Commission [NMHC], 2016). Contemporary Australian policy therefore expects mental health nurses to practise in a way that is simultaneously recovery-oriented, trauma-informed and attentive to physical health (Australian Health Ministers’ Advisory Council [AHMAC], 2013; Australian Commission on Safety and Quality in Health Care [ACSQHC], 2021). This assignment develops a recovery-oriented plan of care for Jack, a 25-year-old consumer admitted with a relapse of schizophrenia. It presents the consumer scenario and mental state examination (MSE) summary, analyses recovery-oriented and trauma-informed practice through the CHIME framework, and sets out a prioritised care plan with medication considerations. The analysis is aligned throughout with the Nursing and Midwifery Board of Australia (NMBA) Registered Nurse Standards for Practice and the National Safety and Quality Health Service (NSQHS) Standards, and treats care planning as something undertaken with Jack rather than delivered to him.
Consumer Scenario
Jack is a 25-year-old man who lives with his mother in south-western Sydney and was, until recently, completing a Certificate III in Carpentry at TAFE NSW. He was diagnosed with schizophrenia at age 23 after a first episode of psychosis and achieved good symptom control on risperidone 4 mg daily under a community mental health team. During the first 12 weeks of treatment, however, his weight rose from 86 kg to 94 kg. Embarrassed by the change and frustrated that his concerns “were not taken seriously”, Jack ceased the medication six weeks ago without informing his team.
Over the past fortnight he has slept poorly, withdrawn from his course, and again begun hearing two male voices commenting on him in a derogatory way, worse at night. He believes his neighbours may be monitoring his movements. He presented to the emergency department with his mother and accepted a voluntary admission to an acute mental health unit under the NSW Mental Health Act 2007. Jack discloses emotional abuse by his stepfather during primary school and a brief period in out-of-home care at age nine, and states that he “does not trust people in uniforms”. He smokes approximately 15 cigarettes per day and rarely drinks alcohol. Admission measurements were height 1.78 m, weight 94 kg, waist circumference 104 cm and blood pressure 128/84 mmHg.
Mental State Examination Summary
Jack’s admission MSE is summarised in Table 1. The overall picture is of a distressed but engaged young man with active positive symptoms, partial insight and preserved cognition. These findings shape the plan: active positive symptoms require support for distress and safety, while intact cognition, help-seeking and a clearly stated reason for stopping medication indicate genuine capacity for collaborative decision-making (Foster et al., 2021).
Table 1: Mental state examination summary at admission
| Domain | Findings |
|---|---|
| Appearance and behaviour | Casually dressed, mildly dishevelled; guarded but cooperative; intermittent eye contact; no psychomotor agitation. |
| Speech | Reduced rate and volume with increased latency; coherent and relevant. |
| Mood and affect | Mood described as “flat and worried”; affect blunted but congruent. |
| Thought form | Generally logical and goal-directed; occasional tangentiality when discussing the voices. |
| Thought content | Persecutory ideas that neighbours are monitoring him; no thoughts of self-harm or harm to others elicited. |
| Perception | Second-person derogatory auditory hallucinations, worse at night; distress rated 8 out of 10; no other perceptual disturbance. |
| Cognition | Alert and oriented to time, place and person; attention mildly reduced. |
| Insight and judgement | Partial insight; links the relapse to stopping medication yet remains uncertain the voices are illness-related; judgement for everyday decisions intact; accepting of support. |
Recovery-Oriented Practice and the CHIME Framework
Australian mental health policy distinguishes clinical recovery, meaning symptom remission and functional improvement, from personal recovery, meaning a satisfying, hopeful and contributing life whether or not symptoms fully resolve (AHMAC, 2013). The National Framework for Recovery-Oriented Mental Health Services commits every Australian service to supporting personal recovery, and the NSQHS Partnering with Consumers Standard converts that policy intent into an accreditation requirement: consumers must be genuine partners in decisions about their own care (ACSQHC, 2021). Recovery orientation is therefore not an optional philosophy for the nurse caring for Jack; it is a regulatory expectation that operates alongside the NMBA (2016) standards on therapeutic relationships and comprehensive assessment.
The most widely used evidence map of personal recovery is the CHIME framework. From a systematic review and narrative synthesis of 97 studies, Leamy et al. (2011) identified five interlinked processes: connectedness, hope and optimism, identity, meaning and purpose, and empowerment, as illustrated in Figure 1. Bird et al. (2014) validated the framework with Australian consumers, who endorsed all five processes while emphasising that practical support needs and stigma shape recovery in the Australian context.
Applied to Jack, each process generates concrete nursing work. Connectedness identifies his mother, his TAFE cohort and peer workers as resources to be protected. Hope is supported by recalling that the voices remitted before and by taking his carpentry ambitions seriously. Identity work involves supporting Jack to remain an apprentice who has an illness rather than becoming defined by a diagnosis. Meaning centres on a graded return to study, and empowerment demands that his medication concerns drive, rather than obstruct, treatment planning. Crucially, recovery orientation does not mean withdrawing clinical treatment; the Royal Australian and New Zealand College of Psychiatrists guidelines explicitly position pharmacological and psychosocial care within a recovery frame (Galletly et al., 2016).
Trauma-Informed Care
Jack’s disclosure of childhood emotional abuse, time in out-of-home care and distrust of “people in uniforms” makes trauma-informed care a precondition for every other intervention. Trauma-informed practice assumes that many consumers carry trauma histories, recognises that standard inpatient routines can re-traumatise, and organises care around safety, trustworthiness, choice, collaboration and empowerment (Kezelman & Stavropoulos, 2019). In an Australian review of inpatient settings, Muskett (2014) cautioned that trauma-informed care often remains rhetorical unless translated into specific, observable behaviours.
For Jack, those behaviours include explaining and seeking permission before any physical contact such as blood pressure measurement or weighing; offering choices about the timing of observations and medication; maintaining consistent staff allocation so that trust can accumulate; and using sensory modulation and early de-escalation so that seclusion and restraint are never reached. These practices align with the NSQHS Comprehensive Care Standard, which requires services to minimise restrictive practices, and with NMBA Standard 2, which frames therapeutic relationships as the foundation of safe nursing work (ACSQHC, 2021; NMBA, 2016). Trauma-informed thinking also reframes interpretation: Jack’s guardedness is understood as a learned protective strategy rather than as poor engagement.
Prioritised Care Plan
Table 2 presents the plan negotiated with Jack during his first 48 hours. Priorities follow clinical reasoning: distress and safety first, then the medication partnership that will determine relapse risk, then physical health, and finally the connectedness and role goals that give the admission purpose. Goals are written in recovery language, and each carries a measurable evaluation consistent with NMBA (2016) Standards 5, 6 and 7 on planning, delivering and evaluating care in partnership with the consumer.
Table 2: Prioritised recovery-oriented care plan for Jack
| Priority | Consumer-centred goal | Nursing interventions | Rationale | Evaluation |
|---|---|---|---|---|
| 1. Distress and safety | “I want the voices to bother me less and to feel safe here.” Jack practises at least two coping strategies for voice-related distress by day 7. | Predictable one-to-one contact each shift; collaborative safety plan covering triggers and early warning signs; coaching in grounding, music through headphones and activity scheduling. | The therapeutic alliance is the platform for all engagement, and structured coping strategies reduce hallucination-related distress (Foster et al., 2021). | Distress rating each shift, targeting 4 or less out of 10 by discharge; safety plan completed within 48 hours; strategies demonstrated by day 7. |
| 2. Medication partnership and relapse prevention | “I want a say in my medication.” Jack participates in shared decision-making and can describe his early warning signs before discharge. | Psychoeducation on relapse; jointly build a relapse-prevention plan with his mother, with consent; document his weight-gain concerns and advocate for medication review with the treating psychiatrist. | Discontinuation commonly follows unaddressed adverse effects; engagement improves when concerns are acted on in genuine partnership (Galletly et al., 2016; ACSQHC, 2021). | Relapse-prevention plan documented, with copies to Jack and his GP; Jack teaches back three early warning signs. |
| 3. Physical health and metabolic risk | “I do not want to keep putting on weight.” Weight stabilised within 2 kg of admission weight at the week 12 review. | Baseline metabolic screen; weekly weighs reviewed with Jack; dietitian referral; daily 30-minute walking program; smoking-cessation support including Quitline referral. | Antipsychotic-related metabolic change drives the mortality gap in severe mental illness and is largely preventable with early monitoring and lifestyle support (Correll et al., 2015; NMHC, 2016). | Monitoring chart complete at baseline and weeks 4, 8 and 12; weight and waist trends reviewed with Jack weekly. |
| 4. Connectedness and meaningful activity | “I want to get back to carpentry.” Jack identifies two personally meaningful goals and connects with one community support before discharge. | Strengths-based assessment; referral to a peer support worker; linkage with the community team and a local early psychosis program; family psychoeducation with his mother. | Connectedness, identity and purpose are core CHIME recovery processes validated with Australian consumers (Leamy et al., 2011; Bird et al., 2014). | Goals recorded in Jack’s own words; first peer-support session attended; community follow-up within 7 days of discharge. |
Medication Considerations and Metabolic Monitoring
Australian guidelines recommend continuing antipsychotic treatment for at least two years after a relapse, which makes Jack’s relationship with his medication a central determinant of his prognosis (Galletly et al., 2016). His cessation was not irrational; it was a predictable response to a significant adverse effect that he felt was dismissed. The nursing role is therefore to ensure that his experience informs prescribing decisions, to provide balanced education about options, and to lead the metabolic monitoring that too often lapses after discharge (NMHC, 2016). Table 3 summarises considerations for the agents most likely to be discussed with him.
Table 3: Antipsychotic considerations and associated nursing monitoring
| Antipsychotic | Key adverse-effect considerations | Nursing monitoring and education |
|---|---|---|
| Risperidone (current history) | Moderate weight gain; hyperprolactinaemia with sexual dysfunction or galactorrhoea; dose-related extrapyramidal effects. | Track weight, waist and prolactin-related symptoms; educate that adverse effects warrant review, not silent cessation. |
| Olanzapine | Highest metabolic burden of the common oral agents, affecting weight, glucose and lipids; sedation. | Requires intensive metabolic monitoring; a poor fit for Jack given his stated weight concerns. |
| Aripiprazole | Comparatively low metabolic and prolactin impact; akathisia and early activation or insomnia. | A switch option Jack may raise with his psychiatrist; monitor for restlessness; morning dosing limits sleep disruption. |
| Clozapine | Reserved for treatment-resistant schizophrenia; agranulocytosis, myocarditis and severe constipation. | Not indicated for Jack at present; would require registry enrolment and scheduled haematological monitoring. |
Monitoring must rest on objective measures, and Jack’s admission data already signal risk. Body mass index (BMI) is weight in kilograms divided by height in metres squared: BMI = 94 / (1.78 × 1.78) = 94 / 3.17 = 29.7 kg/m2, within the overweight range and approaching the obesity threshold of 30 kg/m2 (National Health and Medical Research Council [NHMRC], 2013). His percentage weight change on treatment was (94 – 86) / 86 × 100 = 9.3%, exceeding the 7% threshold regarded as clinically significant antipsychotic-associated weight gain (Correll et al., 2015). His waist circumference of 104 cm also exceeds the 102 cm level at which chronic disease risk is substantially increased for men (NHMRC, 2013). The nursing response is a documented schedule: weight and waist weekly during admission and monthly for the first three months after discharge, with blood pressure, fasting glucose or HbA1c and fasting lipids at baseline, at 12 weeks and then at least annually (Galletly et al., 2016). Shared care with Jack’s general practitioner, supported by a GP mental health treatment plan under Medicare, distributes responsibility so that monitoring survives the transition home.
Conclusion
This assignment has developed a plan of care that positions Jack as the central agent in his own recovery. The CHIME framework converts recovery rhetoric into five workable processes, and each appears in the plan: connection with his mother and peers, hope grounded in previous remission, an identity larger than his diagnosis, a return to meaningful study, and real power over treatment decisions. Trauma-informed care makes that partnership possible for a consumer whose history has taught him to distrust institutions, while structured metabolic monitoring answers the physical health inequity that Equally Well identifies as a national priority (NMHC, 2016). The plan operationalises the NMBA (2016) standards on assessment, planning and evaluation and the NSQHS expectations of partnership and comprehensive care (ACSQHC, 2021). If the relapse that brought Jack to hospital began with a failure of partnership, the true measure of this admission is whether it ends with a durable one.
References
Australian Commission on Safety and Quality in Health Care. (2021). National Safety and Quality Health Service Standards (2nd ed.). ACSQHC.
Australian Health Ministers’ Advisory Council. (2013). A national framework for recovery-oriented mental health services: Guide for practitioners and providers. Commonwealth of Australia.
Australian Institute of Health and Welfare. (2024). Mental health services in Australia. AIHW.
Bird, V., Leamy, M., Tew, J., Le Boutillier, C., Williams, J., & Slade, M. (2014). Fit for purpose? Validation of a conceptual framework for personal recovery with current mental health consumers. Australian and New Zealand Journal of Psychiatry, 48(7), 644-653.
Correll, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015). Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry, 14(2), 119-136.
Foster, K., Marks, P., O’Brien, A. J., & Raeburn, T. (2021). Mental health in nursing: Theory and practice for clinical settings (5th ed.). Elsevier Australia.
Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., Kulkarni, J., McGorry, P., Nielssen, O., & Tran, N. (2016). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry, 50(5), 410-472.
Kezelman, C. A., & Stavropoulos, P. A. (2019). Practice guidelines for clinical treatment of complex trauma. Blue Knot Foundation.
Leamy, M., Bird, V., Le Boutillier, C., Williams, J., & Slade, M. (2011). Conceptual framework for personal recovery in mental health: Systematic review and narrative synthesis. British Journal of Psychiatry, 199(6), 445-452.
Muskett, C. (2014). Trauma-informed care in inpatient mental health settings: A review of the literature. International Journal of Mental Health Nursing, 23(1), 51-59.
National Health and Medical Research Council. (2013). Clinical practice guidelines for the management of overweight and obesity in adults, adolescents and children in Australia. NHMRC.
National Mental Health Commission. (2016). Equally Well consensus statement: Improving the physical health and wellbeing of people living with mental illness in Australia. NMHC.
Nursing and Midwifery Board of Australia. (2016). Registered nurse standards for practice. NMBA.